Investing.com - Financial Markets Worldwide
🥇 First rule of investing? Know when to save! Up to 55% off InvestingPro before BLACK FRIDAYCLAIM SALE

FTSE 100 gains on U.S.-China trade optimism

Published 08/25/2020, 03:11 PM
Updated 08/25/2020, 03:20 PM
© Reuters.
UK100
-
HSBA
-
AZN
-
STAN
-
AVV
-
FTMC
-
FTNMX551030
-
DFSD
-

(For a live blog on European stocks, type LIVE/ in an Eikon
news window)
* FTSE 100 up 0.7%, FTSE 250 adds 0.5%

Aug 25 (Reuters) - The FTSE 100 rose for a second straight
session on Tuesday as a pledge by Washington and Beijing to
stand by their Phase-1 trade pact lifted global sentiment, while
technology firm Aveva jumped after signing a $5 billion takeover
deal.
The export-heavy FTSE 100 .FTSE added 0.7% and the mid-cap
FTSE 250 .FTMC 0.5%, with China-reliant miners .FTNMX1770
and Asia-focussed banks HSBA.L STAN.L among the early
gainers. Aveva Group AVV.L rose 2.3% to the top of the FTSE 100 as
it said it would buy OSIsoft, a privately held maker of
industrial software used to manage plants and factories, for an
enterprise value of $5 billion. AstraZeneca Plc AZN.L rose 0.6% after launching a trial
for an antibody-based treatment for COVID-19. The drugmaker logged its best session in a week on Monday as
a report said the U.S. government was considering fast-tracking
its experimental vaccine, already among the most advanced
vaccine candidates.
Retailer DFS Furniture Plc DFSD.L jumped 13.5% after
saying its performance over the last six weeks was significantly
above its initial expectations.

Latest comments

Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.